Ankylosing spondylitis: open trials in China

24 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07915544
A Study of GKL-006Allo Injection in Patients With Ankylosing Spondylitis
Trial Treatment · Phase 1 · Beijing Gene Key Life Technology Co., Ltd
First Medical Center of Chinese PLA General Hospital, Beijing
Registry updated 2026-11-04
NCT07133633
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Chinese Academy of Medical Science Peking Union Medical College Hospital (Site 3100), Beijing · The First Afflilated Hospital of Bengbu Medical College (Site 3119), Bengbu · The First Hospital Of Jilin University (Site 3103), Changchun · Guangdong Provincial People's Hospital (Site 3110), Guangzhou · The Third Affiliated Hospital of Sun Yat-Sen University (Site 3114), Guangzhou · First Affiliated Hospital of Kunming Medical University (Site 3123), Kunming · The First Affiliated Hospital of Henan University of Science &Technology (Site 3121), Luoyang · Pingxiang People's Hospital (Site 3115), Pingxiang · PEOPLE'S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION (Site 3124), Ürümqi
Registry updated 2026-10-23
NCT07578220
A Randomized Trial of Ultrasound-Guided Acupotomy for Ankylosing Spondylitis
Trial Treatment · China-Japan Friendship Hospital
The Second Affiliated Hospital of Henan University of Chinese Medicine, Henan
Registry updated 2026-10-15
NCT07188285
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
Research · Peking University People's Hospital
Peking University People's Hospital, Beijing
Registry updated 2026-08-26
NCT07724847
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
Research · Chinese PLA General Hospital
Chinese PLA General Hospital, Beijing
Registry updated 2026-07-24
NCT07632599
Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis
Trial Treatment · Phase 1 · Eighth Affiliated Hospital, Sun Yat-sen University
The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen
Registry updated 2026-06-08
NCT07582146
Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world Study
Trial Treatment · Phase 4 · Chinese PLA General Hospital
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital, Beijing
Registry updated 2026-05-12
NCT07556224
Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study
Research · China-Japan Friendship Hospital
China-Japan Friendship Hospital, Beijing
Registry updated 2026-04-29
NCT06844643
The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study
Research · China-Japan Friendship Hospital
China-Japan Friendship Hospital, Beijing
Registry updated 2026-04-13
NCT07509775
Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
Research · China-Japan Friendship Hospital
China-Japan Friendship Hospital, Beijing
Registry updated 2026-04-09
NCT05303285
A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis
Trial Treatment · Phase 4 · Tongji Hospital
Tongji Hospital, Wuhan · Department of RheumatologyTongji Hospital, Wuhan
Registry updated 2026-01-27
NCT07349329
A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
Trial Treatment · Phase 3 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Beijing
Registry updated 2026-01-16
NCT07339566
Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis
Trial Treatment · Phase 2/3 · Lingli Dong
Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Registry updated 2026-01-14
NCT07172360
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Trial Treatment · Phase 3 · Jiangsu vcare pharmaceutical technology co., LTD
Peking University People's Hospital, Beijing
Registry updated 2026-01-02
NCT07261644
A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)
Trial Treatment · Phase 3 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Beijing
Registry updated 2025-12-10
NCT07237568
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
Trial Treatment · Phase 3 · Lynk Pharmaceuticals Co., Ltd
Peking Union Medical College Hospital, Beijing
Registry updated 2025-11-20
NCT06707194
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
Trial Treatment · Phase 4 · Nanfang Hospital, Southern Medical University
The Second Affiliated Hospital of Chongqing Medical University, Chongqing · Ganzhou People's Hospital, Ganzhou · Nan Fang Hospital, Southern Medical University, Guangzhou · Anhui Provincial Hospital, Hefei · Inner Mongolia People's Hospital, Hohhot
Registry updated 2025-06-26
NCT06860750
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
Trial Treatment · Phase 3 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Chinese PLA General Hospital, Beijing
Registry updated 2025-06-22
NCT06988813
Bidirectional Cohort Study of Nanfang Spondyloarthritis
Research · Nanfang Hospital, Southern Medical University
Nanfang Hostipal,Southern Medical University, Guangzhou
Registry updated 2025-05-25
NCT06222671
A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
Trial Treatment · Phase 2 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Beijing · Beijing · Chongqing · Nanjing · Shenzhen · Zhengzhou
Registry updated 2025-03-11
NCT06833112
Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis
Trial Treatment · Phase 4 · The Affiliated Hospital Of Guizhou Medical University
The Affiliated Hospital of Guizhou Medical University, Guiyang
Registry updated 2025-02-18
NCT06766552
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Research · Second Affiliated Hospital, Zhejiang University, School of Medicine
The Second Affiliated Hospital of Zhejiang University, Hangzhou
Registry updated 2025-01-09
NCT06000956
A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
Trial Treatment · Phase 3 · Tasly Pharmaceutical Group Co., Ltd
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing · Dongfang Hospital Beijing University of Chinese Medicine, Beijing · Yunnan Province Hospital of Traditional Chinese Medicine, Kunming · The First Hospital of Lanzhou University, Lanzhou · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · Afﬁliated Hospital of North Sichuan Medical College, Nanchong · The First Hospital of Hebei Medical University, Shijiazhuang · Suzhou Hospital of Traditional Chinese Medicine, Suzhou · The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin · Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2024-11-21
NCT03425812
Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission
Trial Treatment · The First Affiliated Hospital of Xiamen University
The First Affiliated hospital of Xiamen University, Xiamen
Registry updated 2022-04-18

All Ankylosing spondylitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error